|
1) Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med. 1977; 63: 125-30
|
|
|
|
2) Huntly BJ, Shigematsu H, Deguchi K, et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell. 2004; 6: 587-96
|
|
|
|
|
|
3) Naka K, Hoshii T, Hirao A. A novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells. Cancer Sci. 2010; 101: 1577-81
|
|
|
|
|
|
4) Kikuchi A. Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci. 2003; 94: 225-9
|
|
|
|
|
5) Zhao C, Blum J, Chen A, et al. Loss of β-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell. 2007; 12: 528-41
|
|
|
|
|
|
6) Dierks C, Beigi R, Guo GR, et al. Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell. 2008; 14: 238-49
|
|
|
|
|
|
7) Zhao C, Chen A, Jamieson CH, et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature. 2009; 458: 776-9
|
|
|
|
|
|
8) Ito K, Bernardi R, Morotti A, et al. PML targeting eradicates quiescent leukaemia-initiating cells. Nature. 2008; 453: 1072-8
|
|
|
|
|
|
9) Chen Y, Hu Y, Zhang H, et al. Loss of the Alox5 gene impairs leukemia stem cells and prevents chronic myeloid leukemia. Nat Genet. 2009; 41: 783-92
|
|
|
|
|
|
10) Yamazaki S, Iwama A, Takayanagi S, et al. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J. 2006; 25: 3515-23
|
|
|
|
|
|
11) Miyamoto K, Araki KY, Naka K, et al. Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell. 2007; 1: 101-12
|
|
|
|
|
|
12) Yalcin S, Zhang X, Luciano JP, et al. Foxo3 is essential for the regulation of ataxia telangiectasia mutated and oxidative stress-mediated homeostasis of hematopoietic stem cells. J Biol Chem. 2008; 283: 25692-705
|
|
|
|
|
|
13) Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007; 128: 325-39
|
|
|
|
|
|
14) Komatsu N, Watanabe T, Uchida M, et al. A member of Forkhead transcription factor FKHRL1 is a downstream effector of STI571-induced cell cycle arrest in BCR-ABL-expressing cells. J Biol Chem. 2003; 278: 6411-9
|
|
|
|
|
|
15) Naka K, Hoshii T, Muraguchi T, et al. TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010; 463: 676-80
|
|
|
|
|
|
16) Yamazaki S, Iwama A, Takayanagi SI, et al. TGF-β as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood. 2009; 113: 1250-6
|
|
|
|
|
|
17) Yokota A, Kimura S, Tanaka R, et al. Osteoclasts are involved in the maintenance of dormant leukemic cells. Leuk Res. 2010; 34: 793-9
|
|
|
|
|
|
18) Moller GM, Frost V, Melo JV, et al. Upregulation of the TGFβ signalling pathway by Bcr-Abl: implications for haemopoietic cell growth and chronic myeloid leukaemia. FEBS Lett. 2007; 581: 1329-34
|
|
|
|
|
|
19) Zhang B, Strauss AC, Chu S, et al. Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate. Cancer Cell. 2010; 17: 427-42
|
|
|
|
|